These results confirm that Ki-67 immunoexpression is a useful tool to distinguish among benign and malignant tumors, as it has been demonstrated in the malignant areas of other tumors, such as carcinoma ex-PA with scant areas of malignancy that are not clearly evident under H&E stained sections (7-8). Here, MKI67 is linked to carcinoma.